Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% Albumin vs Normal Saline in Early Septic Shock
NCT00819416Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Feb 2009
- Primary completion
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in septic shock, sponsored by Ottawa Hospital Research Institute. Started Feb 2009; status: completed.
02
Drugs
albumin (human)
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00819416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819416.